참고문헌
- Aguiar RC. Therapy-related chronic myeloid leukemia: an epidemiological, clinical and pathogenetic appraisal. Leuk Lymphoma 1998;29:17-26. https://doi.org/10.3109/10428199809058378
- Kantarjian HM, Keating MJ, Walters RS, et al. Therapyrelated leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features. J Clin Oncol 1986;4:1748-1757. https://doi.org/10.1200/JCO.1986.4.12.1748
- Larson RA, Le Beau MM. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans. Chem Biol Interact 2005;153-154:187-195. https://doi.org/10.1016/j.cbi.2005.03.023
- Preston DL, Kusumi S, Tomonaga M, et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res 1994;137(2 Suppl):S68-S97. https://doi.org/10.2307/3578893
- Waller CF, Fetscher S, Lange W. Treatment-related chronic myelogenous leukemia. Ann Hematol 1999;78:341-354. https://doi.org/10.1007/s002770050527
피인용 문헌
- Sequential development of chronic myelogenous leukemia and primary myelofibrosis in a patient with history of large B-cell lymphoma treated with radiotherapy and chemotherapy: two myeloid neoplasms wi vol.95, pp.8, 2014, https://doi.org/10.1007/s00277-016-2707-x
- Chronic Myeloid Leukemia Following Treatment for Primary Neoplasms or Other Medical Conditions vol.150, pp.3, 2014, https://doi.org/10.1093/ajcp/aqy050
- A Case of Preleukemic Chronic Myeloid Leukemia Following Chemotherapy and Autologous Transplantation for T-lymphoblastic Lymphoma vol.40, pp.5, 2014, https://doi.org/10.3343/alm.2020.40.5.417